References
- Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics. Vital Health Stat 1999;10(200):82
- Benbadis SR, Agrawal VK. Partial epilepsies. Available at: http://www.edmedicine.com/neuro/topic623.htm. Accessed April 26, 2003
- Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy (Cochrane Review) In: The Cochrane Library, Issue 1, 2003. Oxford: Update Software. Date of most recent amendment: 3 January 2002
- Zonegran [package insert]. San Diego, CA: Elan Pharmaceuticals Inc; 2000
- Masuda Y, Ishizaki M, Shimizu M. Zonisamide: pharmacology and clinical efficacy in epilepsy. CNS Drug Review 1996;4:341–60
- Leppik IE. Zonisamide. Epilepsia 1999;40(Suppl 5):S23–S29
- Faught E, Ayala R, Montouris GG, Leppik IE, Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57:1774–9
- Leppik IE, Willmore LJ, Homan RW, et al. Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res 1993;14:165–73
- Backonja MM. Use of anticonvulsants for the treatment of neuropathic pain. Neurology 2002;59(Suppl 2):S14–S17
- Seino M, Ohkuma T, et al. Efficacy evaluation of AD-810 (zonisamide): double-blind study comparing with carbamazepine. J Clin Exp Med 1988;144:257–91
- Fukushima K, Yagi K, Seino M, et al. [Phase II clinical trial of a new antiepileptic drug, zonisamide (ZNA) in pediatric epilepsy patients]. Shonika-Rinsho 1987;40:3389–97 [in Japanese]
- Hasegawa S, Ito N, Kaji S, et al. [Clinical evaluation of AD-810 (zonisamide) to partial seizure disorder]. Rinsho-Iyaku 1988;4:189–99 [in Japanese]
- Schmidt D, Jacob R, Loiseau P, et al. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 1993;15:67–73
- Wong IC, Lhatoo SD. Adverse reactions to new anticonvulsant drugs. Drug Safety 2002;23:35–56
- Kayano Y, Mizutsu N, Kinoshita T, et al. [Novel anticonvulsant zonisamide: clinical outcome for treatment of seizure]. Igaku-to-Yakugaku 1987;18:1641–9 [in Japanese]